News & Media
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Swift Biosciences and BillionToOne Partner Together for Commercialization and Manufacturing of EUA Approved COVID-19 Test
Swift Biosciences and BillionToOne Partner Together for Commercialization and Manufacturing of EUA Approved COVID-19 Test
BillionToOne, Sugentech Coronavirus Tests Get FDA Emergency Use Authorization
BillionToOne, Sugentech Coronavirus Tests Get FDA Emergency Use Authorization
BillionToOne secures EUA for RNA extraction-free Covid-19 test
BillionToOne secures EUA for RNA extraction-free Covid-19 test
BillionToOne Granted FDA Emergency Use Authorization for Groundbreaking RNA Extraction-Free qSanger-COVID-19 Assay
BillionToOne Granted FDA Emergency Use Authorization for Groundbreaking RNA Extraction-Free qSanger-COVID-19 Assay
Biocompare - BillionToOne to Offer Sanger Sequencing Based COVID-19 Test
Biocompare - BillionToOne to Offer Sanger Sequencing Based COVID-19 Test
Social Posts